Active Ingredient(s):Dexmethylphenidate Hydrochloride + Serdexmethylphenidate Chloride FDA Approved: * March 2, 2021 Pharm Company: *COMMAVE THERAP Category:ADD / ADHD
Serdexmethylphenidate/dexmethylphenidate, sold under the brand name Azstarys, is a fixed-dose combination medication containing serdexmethylphenidate and dexmethylphenidate which is used to treat attention deficit hyperactivity disorder (ADHD) in people aged six years and older.
It was approved for medical use in the United States in March 2021.
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion